期刊文献+

肝功能异常对慢性收缩性心力衰竭患者预后的影响 被引量:20

Prevalence and prognostic value of liver function abnormalities in patients with chronic systolic heart failure
原文传递
导出
摘要 目的探讨肝功能异常在慢性收缩性心力衰竭(心衰)患者发病率及对预后影响。方法回顾性调查和分析湖北地区8地市12家三级甲等医院2000至2010年心衰住院患者临床资料,所有患者电话随访。根据患者预后分为死亡组和存活组。以单因素和多因素Cox生存分析确认肝功能异常与心衰患者预后关系;双变量相关分析肝功能指标与其他因素的相关性。结果16681例患者纳入本次研究。任一肝功能指标异常的发生率为71.94%(12001/16681)。最常见的为直接胆红素(DBil)升高,γ-谷氨酰转移酶(γ-GT)升高和丙氨酸转氨酶(ALT)升高,分别为33.37%(4863/14574)、32.51%(4337/13341)和30.12%(5024/16681)。碱性磷酸酶(ALP)异常少见,其减低和升高分别为4.51%(559/12397)和3.82%(474/12397)。白蛋白(Alb)减低占23.24%(3408/14664),总胆红素(TBil)升高占19.37%(3231/16681)。DBil升高(HR1.264,95%CI1.103—1.423;P=0.02)、TBil升高(HR1.126,95%CI1.019—1.234;P=0.02)和Alb降低(HR0.889,95%C10.794~0.889;P〈0.01)是心衰总死亡率增加的独立危险因素。相关性分析发现DBil、TBil和Alb与左心室射血分数(LVEF)(r=-0.235,P〈0.01;r=-0.209,P〈0.01;r=0.107,P〈0.01)和右心室舒张末期内径(r=0.149,P〈0.01;r=0.154,P〈0.01;r=-0.086,P〈0.01)相关。结论DBil升高、Alb降低和TBil升高是心衰总死亡率增加的独立危险因素。LVEF减低和右心室舒张末期内径增加是影响慢性收缩性心衰患者肝功能的主要因素。 Objective To evaluate systemically the prevalence and prognostic values of liver function abnormalities in patients with chronic systolic heart failure (HF) have not been systematically evaluated. Methods A total of 16 681 hospitalized patients with a diagnosis of chronic systolic HF and left ventricular ejection fraction (LVEF) 〈 50% were recruited from 12 hospitals in Hubei Province. All patients were followed up by telephone contacts. And they were divided into the death and survival groups according to the follow-up results. Results Over a median follow-up period of 3 years, 6453 (38. 69% ) patients died. The prevalence of liver function abnormality was 71.94% ( 12 001/16 681 ). The elevations of direct bilirubin, γ-glutamyl-transferase and alanine aminotransferase were the most common findings accounting for 33. 37 % (4863/14 574), 32. 51% (4337/13 341 ) and 30. 12% (5024/16 681 ) respectively. The abnormality of alkaline phosphatase was rare and its increase and decrease accounted for 3. 82% (474/12 397) and 4. 51% (559/12 397 ) respectively. The prevalence of low albumin and total bilirubin elevation was 23.24% (3408/14 664) and 19. 37% (3231/16 681). And high direct bilirubin (HR 1. 264, 95% CI 1. 103 - 1. 423 ; P = 0. 02), high total bilirubin ( HR 1.126, 95 % CI 1.019 - 1. 234 ; P = 0. 02) and low albumin ( HR 0. 889, 95% CI 0.794 -0. 889; P 〈 0.01 )were determined as the independent risk factors of total mortality. There were the correlations of LVEF with direct bilirubin( r = - 0. 235, P 〈 0. 01 ) , total bilirubin ( r = - 0. 209, P 〈 0. 01 ), albumin ( r = 0. 107, P 〈 0. 01 ) and right ventricular end-diastolic diameter (RVDD) with direct bilirubin(r = 0. 149, P 〈 0. 01 ), total bilirubin ( r = 0. 154, P 〈 0. 01 ) and albumin (r = - 0. 086, P 〈 0. 01 ). Conclusion The prevalence of liver function abnormalities is high in patientswith chronic systolic HF. Low albumin, high direct bilirubin and high tot
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第38期2673-2677,共5页 National Medical Journal of China
关键词 心力衰竭 充血性 肝功能不全 预后 回归分析 Heart failure, congestive Hepatic insufficiency Prognosis Regression analysis
  • 相关文献

参考文献13

  • 1Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur J Heart Fail,2008,10:933-989. 被引量:1
  • 2Schaufelberger M,Swedberg K,K(ó)ter M,et al.Decreasing oneyear mortality and hospitalization rates for heart failure in Sweden ;Data from the Swedish Hospital Diacharge Registry 1988 to 2000.Eur Heart J,2004,25:300-307. 被引量:1
  • 3Levy D,Kenchaiah S,Lardon MG,et al.Long-term trends in the incidence of and survival with heart failure.N Engl J Med,2002,347:1397-1402. 被引量:1
  • 4Allen LA,Felker GM,Pocock S,et al.Liver function abnormalities and outcome in patients with chronic heart failure:data from the Candesartan in Heart Failure:Assessment of Reduction in Mortality and Morbidity (CHARM) program.Eur J Heart Fail,2009,11:170-177. 被引量:1
  • 5Batin P,Wickens M,McEntegart D,et al.The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure.Eur Heart J,1995,16:1613-1618. 被引量:1
  • 6Reinhartz O,Farrar DJ,Hershon JH,et al.Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge totransplantation.J Thorac Cardiovasc Surg,1998,116:633-640. 被引量:1
  • 7Shinagawa H,Inomata T,Koitabashi T,et al.Prognosticsigniticance of increased serum bilirubin levels coincident with cardiac decompeasation in chronic heart failure.Circ J,2008,72:364-369. 被引量:1
  • 8Lau GT,Tan HC,Kritharides L.Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation.Am J Cardiol,2002,90:1405-1409. 被引量:1
  • 9van Deursen VM,Damman K,Hillege HL,et al.Abnormal liver function in relation to hemodynamic profile in heart failure patients.J Card Fail,2010,16:84-90. 被引量:1
  • 10Beltowski J,Wójcicka G,Jararoz-Wi(s)niewska A.Adverse effects of statins-mechanisms and consequences.Curr Drug Saf,2009,4:209-228. 被引量:1

二级参考文献4

共引文献24

同被引文献123

引证文献20

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部